Top Regulatory News Stories – Week Ending April 6, 2018

This week saw the submission of two new NDAs, two complete response letters, and one refusal to file.  Here are the top regulatory news stories for this week: Alkermes announced that it received a Refusal to File letter from the FDA regarding its NDA for ALKS 5461, a once-daily, oral investigational medicine with a novel[…]